| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/22/2005 | CA2238003C Impedimetric detection system and method of production thereof |
| 02/19/2005 | CA2440499A1 A method for detecting a risk for sids in prenatal and new born infants |
| 02/17/2005 | WO2005015236A2 A method for predicting the progression of adenocarcinoma |
| 02/17/2005 | WO2005015211A1 Solid support for immobilizing nucleic acid molecule |
| 02/17/2005 | WO2005015205A2 Use of sap |
| 02/17/2005 | WO2005015181A1 Method and kit for determining the metabolic stability of test substances |
| 02/17/2005 | WO2005015161A2 Imaging regulated protein-protein interactions in cells and living animals by enhanced luciferase protein fragment complementation |
| 02/17/2005 | WO2005015155A2 Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol |
| 02/17/2005 | WO2005015154A2 Autocatalysis/yeast two-hybrid assay |
| 02/17/2005 | WO2005014863A1 Mutations in ion channels |
| 02/17/2005 | WO2005014861A1 Genetic markers of food allergy |
| 02/17/2005 | WO2005014860A2 Biomolecule analysis by rolling circle amplification and sers detection |
| 02/17/2005 | WO2005014859A1 Methods and compositions for inhibiting herpesviral replication |
| 02/17/2005 | WO2005014858A2 Qtl 'mapping as-you-go' |
| 02/17/2005 | WO2005014857A2 Nucleic acid arrays for detecting multiple strains of a non-viral species |
| 02/17/2005 | WO2005014856A1 Sensitivity test to predict efficacy of anti-cancer therapies |
| 02/17/2005 | WO2005014855A1 Method for detecting contaminants in pharmaceutical anthracycline products |
| 02/17/2005 | WO2005014854A1 Materials and methods for colorectal cancer screening, diagnosis, and therapy |
| 02/17/2005 | WO2005014853A1 Comparative expression analysis for the identification of genes responsible for phenotypic differences |
| 02/17/2005 | WO2005014852A1 Microarrays of immobilized biomolecules, production thereof, and use thereof |
| 02/17/2005 | WO2005014851A2 Method and kit for assessing the risk of cardiovascular pathologies with atheromatous etiology |
| 02/17/2005 | WO2005014850A2 Systems and methods for analyzing nucleic acid sequences |
| 02/17/2005 | WO2005014846A2 Methods for identifying risk of breast cancer and treatments thereof |
| 02/17/2005 | WO2005014818A1 Gene overexpressed in cancer |
| 02/17/2005 | WO2005014809A1 Polypeptide specific to liver cancer, polynucleotide encoding the polypeptide and rna molecule inhibiting the expression of the polypeptide |
| 02/17/2005 | WO2005014796A2 Methods and compositions for seamless cloning of nucleic acid molecules |
| 02/17/2005 | WO2005014795A2 Osteoarthritis biomarkers and uses thereof |
| 02/17/2005 | WO2005014789A2 Tandem repeat determination by concurrent analysis of multiple tandem duplex configurations |
| 02/17/2005 | WO2005014788A2 Tssk4: a human testis specific serine/threonine kinase |
| 02/17/2005 | WO2005014786A2 Enhanced engineered chromosome formation from alpha satellite with artificially increased density of cenp-b boxes |
| 02/17/2005 | WO2005014785A2 Conditionally-immortalized hematopoietic progenitor cell lines |
| 02/17/2005 | WO2005014784A2 System for molecular imaging |
| 02/17/2005 | WO2005014781A2 Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium |
| 02/17/2005 | WO2005014616A2 Complexes of gpcr142 and relaxin3 or insl5, and their production and use |
| 02/17/2005 | WO2005014610A1 Nucleoside capable of releasing functional unit through oxidation and process for producing oligonucleotide containing the same |
| 02/17/2005 | WO2005013905A2 SENSE ANTIVIRAL COMPOUND AND METHOD FOR TREATING ssRNA VIRAL INFECTION |
| 02/17/2005 | WO2005013899A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 02/17/2005 | WO2005013893A2 Cancer related genes |
| 02/17/2005 | WO2005013889A2 Truncated fragments of alpha-synuclein in lewy body disease |
| 02/17/2005 | WO2005013809A2 Diagnostic and therapeutics for osteoporosis |
| 02/17/2005 | WO2005013682A2 Animal model for the analysis of tumor metastasis |
| 02/17/2005 | WO2005002324A3 Method of producing double low restorer lines of brassica napus having a good agronomic value |
| 02/17/2005 | WO2004108883A3 Transducible dna-binding proteins |
| 02/17/2005 | WO2004107958A3 Sterol markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease |
| 02/17/2005 | WO2004106556A3 Fluorescence-based dna primase assays |
| 02/17/2005 | WO2004099443A3 Method for selection of optimal microarray probes |
| 02/17/2005 | WO2004099131A3 Compounds having a fused, bicyclic moiety for binding to the minor groove of dsdna |
| 02/17/2005 | WO2004094986A3 System and method for electrochemical detection of biological compounds |
| 02/17/2005 | WO2004087730A8 Method for producing diverse libraries of encoded polymers |
| 02/17/2005 | WO2004087044A3 Drug target |
| 02/17/2005 | WO2004083398A3 Therapeutic uses of hmgn1 and hmgn2 |
| 02/17/2005 | WO2004079343A3 Sample preparation for colorimetric and fluorescent assays as implemented on optical analysis discs |
| 02/17/2005 | WO2004053453A3 Modulation of bub 1-beta expression |
| 02/17/2005 | WO2004051218A3 Multiplex amplification of polynucleotides |
| 02/17/2005 | WO2004031402A3 Methylation profile of cancer |
| 02/17/2005 | WO2004016805A3 Immunostimulatory nucleic acids |
| 02/17/2005 | WO2004010850A3 Method for identifying cancer risk |
| 02/17/2005 | WO2004005457A3 Tfc/ beta-catenin regulated genes for treating cancer |
| 02/17/2005 | WO2004003820A8 System, method, device, and computer program product for extraction, gathering, manipulation, and analysis of peak data from an automated sequencer |
| 02/17/2005 | WO2004003223A3 New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance |
| 02/17/2005 | WO2003102214A3 Method for efficient rna interference in mammalian cells |
| 02/17/2005 | WO2003064675A8 Rapid methods and devices for the detection of coliform and the detection and confirmation of e. coli |
| 02/17/2005 | WO2003050258A3 Endogenous retrovirus polypeptides linked to oncogenic transformation |
| 02/17/2005 | WO2003025131A3 Protein modification and maintenance molecules |
| 02/17/2005 | WO2002074913A3 Nucleic acid-associated proteins |
| 02/17/2005 | US20050039226 Expression vector comprising nucleotide sequences for conferring insect resistance to a plant; transgenic insect resistant maize |
| 02/17/2005 | US20050039224 Producing forced open regulatory nucleotide sequence complex for use as tool in conntrolling heterologous gene expression in transfected cells |
| 02/17/2005 | US20050039221 Phenotypic effects of ubiquinone deficiencies and methods of screening thereof |
| 02/17/2005 | US20050039220 Labeled coronavirus protein for use as diagnostic tool in detection of viral infection; viricides and vaccine development for treatment and prevention of respiratory system disorders |
| 02/17/2005 | US20050038454 Anastomotic delivery system |
| 02/17/2005 | US20050038329 Methods and kits for assays of rapid screening of diabetes |
| 02/17/2005 | US20050038233 obtaining a sequence-defined molecular weight markers that provide an accurate and robust calibration set for determinations of molecular weight of production batches; subjecting the molecular weight markers to column chromatography to establish a relationship between retention time and molecular weight |
| 02/17/2005 | US20050038229 Protein scaffolds for antibody mimics and other binding proteins |
| 02/17/2005 | US20050037991 Synthesis and compositions of 2'-terminator nucleotides |
| 02/17/2005 | US20050037987 Methods of identifying kinases and uses thereof |
| 02/17/2005 | US20050037985 Administering CpG oligonucleotide to patient infected with human immunodeficiency virus |
| 02/17/2005 | US20050037971 Use of hepcidin as a regulator of iron homeostasis |
| 02/17/2005 | US20050037956 Screening method for agents useful in treating diabetes |
| 02/17/2005 | US20050037955 Bactericides; fungicides; isolated polypeptides; inflammatory bowel disorders; infections |
| 02/17/2005 | US20050037949 Mannose binding lectin and uses thereof |
| 02/17/2005 | US20050037512 Such as luminescent tris-4,7-diphenyl-1,10-phenanthroline ruthenium (II) salt; drug screening |
| 02/17/2005 | US20050037504 Quantifying cholesterol in high-density lipoproteins in a single step assay using a dry slide; diagnosing cardiovascular disorders |
| 02/17/2005 | US20050037497 Compounds and methods to enhance rAAV transduction |
| 02/17/2005 | US20050037495 Human CNS cell lines and methods of use therefor |
| 02/17/2005 | US20050037476 Modified Wee1, crystals of peptide: inhibitor complexes containing such modified Wee1, and methods of use thereof |
| 02/17/2005 | US20050037464 Prokineticin polypeptides, related compositions and methods |
| 02/17/2005 | US20050037454 Expression vector comprising nuclelotide sequences coding osteoblast protein for use in diagnosis, prevention and treatment of osteoporosis and bone resorption disorders |
| 02/17/2005 | US20050037451 Method of using potassium permanganate in water analysis |
| 02/17/2005 | US20050037450 Novel targets for lithium therapy |
| 02/17/2005 | US20050037449 Agent for controlling circadian rhythm disorder |
| 02/17/2005 | US20050037445 analyzing molecules expressed on the cell surface of cancer cells and comparing to nonmalignant cells; screening for cancer specific promoters to be used singly or in combination for delivery and expression of therapeutic genes for treatment of cancer |
| 02/17/2005 | US20050037444 Method for identification isolation and production of antigens to a specific pathogen |
| 02/17/2005 | US20050037443 Detection of sarcocystis neurona |
| 02/17/2005 | US20050037436 Test systems and the use thereof for identifying and characterizing compounds |
| 02/17/2005 | US20050037435 Generating new compounds without predetermining a desired structure or composition; rational drug design |
| 02/17/2005 | US20050037434 Immunolobulin which interferes with lysosome associated membrane protein 1(LAMP-1) ligand binding for use in treatment and prevention of autoimmune diabetes |
| 02/17/2005 | US20050037432 Macroglobulin peptides for use as diagnostic indicator of osteoarthritis, bone and tissue disorders |
| 02/17/2005 | US20050037428 Artificial receptors including reversibly immobilized building blocks, the building blocks, and methods |
| 02/17/2005 | US20050037419 Compositions and methods relating to lung specific genes and proteins |
| 02/17/2005 | US20050037417 Screening peptide library for amino acid sequences which specifically target/hybridize to brain and kidney tissue; immunodiagnostics; tissue targeted therapy |